The value of anti-Mullerian hormone in the management of polycystic ovary syndrome in adolescents

References

• Arowojolu A, Gallo M, Lopez L, et al. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2012;11:CD004425.
   Google Scholar
• Fauser B, Tarlatzis R, Rebar R, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97:28–38.
   PubMed Web of Science ®Google Scholar
• Carmina E, Rosato F, Janni A, et al. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab. 2006;91:2–6.
   PubMed Web of Science ®Google Scholar
• Rosenfield R. Clinical review: adolescent anovulation: maturational mechanisms and implications. J Clin Endocrinol Metab. 2013;98:3572–3583.
   PubMed Web of Science ®Google Scholar
• Witchel S, Oberfield S, Rosenfield R, et al. The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr. 2015;83:376–389.
   Web of Science ®Google Scholar
• Sultan C, Paris F. Clinical expression of polycystic ovary in adolescent girls. Fertil Steril. 2006;86:S6.
   PubMed Web of Science ®Google Scholar
• Teede H, Misso M, Costello M, et al. International PCOS network recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33:1602–1618.
   PubMed Web of Science ®Google Scholar
• Dumont A, Robin G, Catteau-Jonard S, et al. Role of anti-mullerian hormone in pathophysiology, diagnosis and treatment of polycystic ovary syndrome: a review. Reprod Biol Endocrinol. 2015;13:137.
   PubMed Web of Science ®Google Scholar
• Pigny P, Jonard S, Robert Y, et al. Serum anti-mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:941–994.
   PubMed Web of Science ®Google Scholar
• Pellatt L, Hanna L, Brincat M, et al. Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab. 2007;92:240–245.
   PubMed Web of Science ®Google Scholar
• Koutlaki N, Dimitraki M, Zervoudis S, et al. The relationship between anti-Müllerian hormone and other reproductive parameters in normal women and in women with polycystic ovary syndrome. J Med Life. 2013;15:6146–6150.
   Google Scholar
• La Marca A, Giulini S, Tirelli A, et al. Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod. 2007;22:766–771.
   PubMed Web of Science ®Google Scholar
• Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41.
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Ricchieri F, Lanzoni C. Use of metformin in the treatment of polycystic ovary syndrome. Womens Health (Lond). 2010;6:577–593.
   PubMedGoogle Scholar
• Harborne L, Fleming R, Lyall H, et al. Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet. 2003;361:1894–1901.
   PubMed Web of Science ®Google Scholar
• Mashiach R, Amit A, Hasson J, et al. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome. Fertil Steril. 2010;93:2299–2302.
   PubMed Web of Science ®Google Scholar
• Moran L, Hutchison S, Norman R, et al. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2011;16:2.
   Google Scholar
• Practice Committee of the American Society for Reproductive Medicine. Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome. Fertil Steril. 2008;90:69–73.
   Web of Science ®Google Scholar
• Artini P, Di Berardino O, Papini F, et al. Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study. Gynecol Endocrinol. 2013;29:375–379.
   PubMed Web of Science ®Google Scholar
• Nardo L, Yates P, Roberts S, et al. The relationships between AMH, androgens, insulin resistance, and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Hum Reprod. 2009;24:2917–2923.
   PubMed Web of Science ®Google Scholar
• Norman R, Dewailly D, Legro R, et al. Polycystic ovary syndrome. Lancet. 2007;370:685–697.
   PubMed Web of Science ®Google Scholar
• Park H, Cho G, Ahn K, et al. Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf). 2010;72:26–31.
   PubMed Web of Science ®Google Scholar
• Hangen C, Aksqlaede L, Sorensen K, et al. Individual serum levels of anti-müllerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study. Hum Reprod. 2012;27:861–866.
   PubMed Web of Science ®Google Scholar
• Sopher A, Grigoriev G, Laura D, et al. Anti-mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents. J Pediatri Endocrinol Metab. 2014;27:1175–1179.
   PubMed Web of Science ®Google Scholar
• Brown M, Park A, Shayya R, et al. Ovarian imaging by magnetic resonance in adolescent girls with polycystic ovary syndrome and age-matched controls. J Magn Reson Imaging. 2013;38:689–693.
   PubMed Web of Science ®Google Scholar
• Asanidze E, Khristesashvili J, Pkhaladze L, et al. Correlation of anti-Mullerian Hormone with hormonal and ovarian morphological characteristics in patients with PCOS and insulin resistance. Georgian Med News. 2018;2:34–40.
   Google Scholar
• Fonseca H, Brondi R, Piovesan F, et al. Anti-Mullerian hormone and insulin resistance in polycystic ovary syndrome. Gynecol Endocrinol. 2014;30:667–670.
   PubMed Web of Science ®Google Scholar
• Villaroel C, Merino P, Lopea F, et al. Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Müllerian hormone. Hum Reprod. 2011;26:2861–2868.
   PubMed Web of Science ®Google Scholar
• Pinola P, Morin-Papunen L, Bloigu A, et al. Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study. Hum Reprod. 2014;29:2317–2325.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod. 2004;19:41–47.
   PubMed Web of Science ®Google Scholar